Literature DB >> 29169171

MiRNAs are Unlikely to be Involved in Retinoid Receptor Gene Regulation in Pancreatic Cancer Cells.

Shuai Yin1, Tim Bleul1, Yifan Zhu2,3, Orkhan Isayev1,4, Jens Werner1,5, Alexandr V Bazhin1,5.   

Abstract

BACKGROUND/AIMS: Retinoid receptors and retinoic acid were reported to be down-regulated in pancreatic duct adenocarcinoma (PDAC) compared to normal pancreas. Yet the mechanism of the down-regulation of retinoid receptors is not well defined. The aim of this study was to find out whether selected dysregulated miRNAs in PDAC are responsible for the decreased level of retinoid receptors.
METHODS: Bioinformatics, real-time PCR, western blot analysis as well as molecular manipulation with miRNA in cells of PDAC were carried out.
RESULTS: We first performed bioinformatics research to identify conserved target sequences for deregulated miRNAs within the 3'UTR region of retinoid receptor mRNA. This research revealed binding sites for miR-138, -27a, -27b, -206, -613, -9-5p, -27a/b-3p and -27a. Next, we investigated the expression of selected retinoid receptors and miRNAs in PDAC cell lines and in the Human Pancreatic Duct Epithelial (HPDE) cell line. Further, we investigated the effects of modifying expression levels of selected miRNAs using miRNA inhibitors or mimics. We demonstrated that none of these miRNAs can target the selected retinoid receptors in vitro.
CONCLUSIONS: miR-27a, miR-27b, miR-9, miR10a and miR-10b were up-regulated in PDAC cells compared to HPDE cells. The up-regulation of these miRNAs was not responsible for the down-regulation of RARα, RARβ, RXRα and RXRβ in PDAC cells.
© 2017 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  MiRNA; Pancreatic cancer; Retinoid receptors

Mesh:

Substances:

Year:  2017        PMID: 29169171     DOI: 10.1159/000485276

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  5 in total

1.  MicroRNA-876-3p functions as a tumor suppressor gene and correlates with cell metastasis in pancreatic adenocarcinoma via targeting JAG2.

Authors:  Fu Yang; Wan Jun Zhao; Cong Li Jia; Xiao Kai Li; Qiang Wang; Zi Li Chen; De Quan Jiang
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

Review 2.  Non-coding RNA crosstalk with nuclear receptors in liver disease.

Authors:  Jianguo Wu; Laura E Nagy; Suthat Liangpunsakul; Li Wang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-01-24       Impact factor: 5.187

3.  Treatment with somatostatin analogs induces differentially expressed let-7c-5p and mir-3137 in small intestine neuroendocrine tumors.

Authors:  Florian Bösch; Alexandr V Bazhin; Sabine Heublein; Katharina Brüwer; Thomas Knösel; Florian P Reiter; Christoph J Auernhammer; Markus O Guba; Christine Spitzweg; Jens Werner; Martin K Angele
Journal:  BMC Cancer       Date:  2019-06-13       Impact factor: 4.430

4.  miR-202 Inhibits Cell Proliferation, Migration, and Invasion by Targeting Epidermal Growth Factor Receptor in Human Bladder Cancer.

Authors:  Liqing Zhang; Jianjiang Xu; Gaodi Yang; Heng Li; Xiuxia Guo
Journal:  Oncol Res       Date:  2018-01-03       Impact factor: 5.574

5.  Experimental postoperative ileus: is Th2 immune response involved?

Authors:  Sisi Lin; Florian Kühn; Tobias S Schiergens; Andrey A Zamyatnin; Orkhan Isayev; Eldar Gasimov; Jens Werner; Yongyu Li; Alexandr V Bazhin
Journal:  Int J Med Sci       Date:  2021-06-16       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.